|
|
|
|
|
|
|
|
What will define the next generation of RNA therapeutics? This collection brings together industry experts to examine the innovations transforming RNA development, from advanced delivery systems and AI-enabled discovery to manufacturing scale-up and regulatory readiness. Gain valuable insights into emerging applications across oncology, vaccines, gene editing, and personalized medicine while exploring the challenges and opportunities shaping the future of the field. Click to learn more.
|
|
|
|
|
|
|
|
By Advancing RNA Live
|
AbbVie’s Elaine Peters, Sanofi’s Philippe Talaga, and Tessera’s Ilya Shestopalov highlight the technical limitations of legacy analytical methods in evaluating and measuring mRNA-LNP concentration, structure, purity, integrity, and impurities.
|
|
|
|
|
|
|
|
By Steve Wolk, Ph.D., Sinawali Biotechnology Solutions
|
Exploring the race to achieve large gene knock-ins, emerging editing platforms, and how overcoming this challenge could unlock therapies for many inherited diseases.
|
|
|
|
|
|
|
|
By Kyle Tynan, National Institute of Standards and Technology (NIST)
|
NIST research introduces a gentle SEC method that separates dsRNA impurities from IVT mRNA by tweaking buffer pH, achieving 81.8% target recovery without transcript damage.
|
|
|
|
|
|
|
|
By Andreas N. Kuhn, Ph.D. and Jan Falcke, BioNTech SE
|
RNA therapeutics are entering a new era where analytical platforms drive scalability, regulatory confidence, manufacturing flexibility, and the development of increasingly complex products.
|
|
|
|
|
|
|
|
|
|
|
|
Elevating mRNA Manufacturing Toward GMP-Readiness
|
|
White Paper | MilliporeSigma
|
The mRNA Technology Transfer Program expands LMIC manufacturing capabilities. Discover how strategic industry collaboration creates a reliable, equitable model for global health access.
|
|
|
|
|
|
|
|
|
|
Research-Scale Oligonucleotide Workflow
|
|
Infographic | Cytiva
|
Get a clear view of oligonucleotide development from synthesis to purification and filtration with practical insights to help you streamline workflows and stay ahead in the fight against disease.
|
|
|
|
|
|
|
|
|
|
Cell 2026 | 12-13 November, London, UK
|
Advanced therapy development moves fast, and the companies shaping it are the ones connecting science, scale and strategy in the same room. Cell 2026 is where that happens. Partner with us to reach 800+ senior pharma, biotech and R&D decision-makers through guaranteed 1:1 meetings, speaking slots, roundtables and tailored digital campaigns. Get in touch and we'll design a package around your objectives.
|
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
